| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.1M | -88.1% |
| R&D Expense | $141.2M | +45.6% |
| SG&A Expense | $36.3M | +13.8% |
| Operating Income | -$185.1M | -86.9% |
| Pre-tax Income | -$183.5M | -82.0% |
| Income Tax | $4.3M | +107.4% |
| Net Income | -$187.9M | -82.5% |
| EPS (Basic) | -$2.92 | -29.2% |
| EPS (Diluted) | -$2.92 | -29.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.4M | -36.5% |
| Short-term Investments | $262.9M | +150.1% |
| Current Assets | $385.6M | +28.3% |
| Total Assets | $574.1M | +1.8% |
| Current Liabilities | $50.8M | +26.8% |
| Total Liabilities | $132.1M | +20.0% |
| Stockholders' Equity | $441.9M | -2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.5M | -14.3% |
| Capital Expenditures | $1.7M | -12.0% |
| Investing Cash Flow | -$100.0M | +11.2% |
| Financing Cash Flow | $151.4M | -27.7% |
| Free Cash Flow | -$119.1M | -13.9% |